Orexo AB et al v. Actavis Elizabeth LLC et al
| Orexo AB and Orexo US, Inc. |
| Actavis Elizabeth LLC, Actavis Pharma, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. |
| 1:2017cv00205 |
| February 28, 2017 |
| US District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Gregory M. Sleet |
| Patent |
| 35 U.S.C. ยง 271 |
| Plaintiff |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
300
MEMORANDUM OPINION Signed by Judge Colm F. Connolly on 12/11/2019. (nmf)
|
|
Filing
258
MEMORANDUM OPINION Signed by Judge Colm F. Connolly on 3/12/2019. (nmf)
|
|
Filing
161
ORDER ADOPTING REPORT AND RECOMMENDATIONS 108 ; Order granting 115 Motion to Adopt the Amended Report and Recommendation. Signed by Judge Colm F. Connolly on 11/9/2018. (nmf)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
